The present invention encompasses compounds of general formula (1) wherein the groups R
0
to R
3
and L are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.